Gland Pharma Ltd (NSE:GLAND) reports a 6% revenue increase, driven by US market performance and strategic product launches.

For the base business (Gland), quarterly revenue increased 1% YoY, with half-yearly revenue up 2%. Quarterly EBITDA for the ...

Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, today announced the appointment of Rob Lauzen as chief financial ...

Kimberly‑Clark said on Nov. 3, 2025 that it is planning to acquire Kenvue, the former Johnson & Johnson unit and maker of ...

TG Therapeutics, Inc. posted a strong Q3 with soaring Briumvi sales and increased guidance. Click for my updated look at TGTX ...

Indian CRDMO sector is experiencing a sustained growth phase, underpinned by recurrent global contract wins, new client ...

On October 29, TD Cowen a‌na​lyst Brendan Smith initiated coverage of West Pharmaceutical Services, Inc. (NYSE:WST) with a Buy rating and a‍ pr‌ice⁠ target of $350, as reported by The Fly.

For years, a Southside Virginia couple has relied on the Rite Aid in Lawrenceville for pharmacy services. But in June, the ...

ARS Pharma to showcase a late-breaking oral presentation and six poster presentations highlighting real world impact of neffy® (epinephrine nasal spray) ...

The private placement to Sound Bioventures, together with the proceeds from the recently announced financing round in which Karolinska Development participated, will enable BOOST Pharma to accelerate ...

Find all the latest Q2 results 2025 updates of Bharti Airtel, Titan Company, Power Grid Corporation of India, Ambuja Cements, ...

Marc Filippino Good morning from the Financial Times. Today is Tuesday, November 4th, and this is your FT News Briefing.